Subscribe to RSS
DOI: 10.1055/s-0030-1260260
Asymmetric Syntheses of S,S-Dialkyl-Substituted Sulfoximines and Related Heterocycles
Publication History
Publication Date:
17 October 2011 (online)
Abstract
Enantiomerically enriched forms of a sulfoximine-based myristic acid analogue are prepared using either an asymmetric desymmetrization with a chiral base, or an enantioselective oxidation procedure as key steps. Additionally, a variety of 2-oxa-2-alkyl 3,4-dihydro 2,1-benzothiazines are synthesized via intramolecular metal-catalyzed N-arylation of appropriately functionalized sulfoximines with tethered 2-bromoaryl substituents. In turn, the sulfoximines are prepared by lithiation-alkylation sequences including enantioselective deprotonation steps or the use of an optically active sulfoxide. Using this methodology, the range of accessible 3,4-dihydro 2,1-benzothiazine derivatives is expanded.
Key words
alkyl sulfoximines - dihydro benzothiazines - desymmetrization - cyclizations - copper
- Supporting Information for this article is available online:
- Supporting Information
- For reviews, see:
-
1a
Reggelin M.Zur C. Synthesis 2000, 1 -
1b
Harmata M. Chemtracts 2003, 16: 660 -
1c
Okamura H.Bolm C. Chem. Lett. 2004, 33: 482 -
1d
Bolm C. In Asymmetric Synthesis with Chemical and Biological MethodsEnders D.Jaeger K.-E. Wiley-VCH; Weinheim: 2007. p.149 -
1e
Worch C.Mayer AC.Bolm C. In Organosulfur Chemistry in Asymmetric SynthesisToru T.Bolm C. Wiley-VCH; Weinheim: 2008. p.209 -
1f
Bentley R. Chem. Soc. Rev. 2005, 34: 609 - 2 For recent patents involving sulfoximines,
see references 3 and 4 in:
García Mancheño O.Dallimore J.Plant A.Bolm C. Adv. Synth. Catal. 2010, 352: 309 -
3a
Bentley HR.McDermott EE.Pace J.Whitehead JK.Moran T. Nature 1950, 165: 150 -
3b
Bentley HR.McDermott EE.Whitehead JK. Nature 1950, 165: 735 - 4 For a key publication in this area,
see:
Brandt J.Gais H.-J. Tetrahedron: Asymmetry 1997, 8: 909 - For early reports on the inhibitory activity of methionine sulfoximine, see:
-
5a
Pace J.McDermott EE. Nature 1952, 169: 415 -
5b
Meister A. Science 1983, 220: 472 - From these and subsequent studies it is known that for this particular dialkyl sulfoximine the (S,S)-diastereoisomer is the most active.
- 6 For a recent example, where a mixture
of stereoisomers of buthionine sulfoximine (BSO) was used to study
induced apoptotic cell death, see:
Takahashi K.Tatsunami R.Oba T.Tampo Y. Biol. Pharm. Bull. 2010, 33: 556 - 7
McDonald IA.Nyce PL.Ku GS.Bowlin TL. Bioorg. Med. Chem. Lett. 1993, 3: 1717 - 8
Jackson TE. inventors; (Sandoz-Wander, Inc., USA) US Patent 4031227. ; Chem. Abstr. 1977, 87, 102318 - 9
McGrath MJ.Bolm C. Beilstein J. Org. Chem. 2007, 3: 33 -
10a
Kagan HB.Dunach E.Nemecek C.Pitchen P.Samuel O.Zhao S.-H. Pure Appl. Chem. 1985, 1911 -
10b
Capozzi MAM.Cardellicchio C.Naso F.Tortorella P. J. Org. Chem. 2000, 65: 2843 -
10c For a review, see:
Capozzi MAM.Cardellicchio C.Naso F. Eur. J. Org. Chem. 2004, 1855 - For syntheses of structurally related 2,1-benzothiazine and 1,2-benzoisothiazole derivatives by alternative pathways, see:
-
11a
Harmata M.Kahraman M. J. Org. Chem. 1998, 63: 6845 -
11b
Harmata M.Pavri N. Angew. Chem. Int. Ed. 1999, 38: 2419 -
11c
Hong X.Harmata M. J. Am. Chem. Soc. 2003, 125: 5754 -
11d
Harmata M.Rayanil K.-o.Gomes MG.Zheng P.Calkins NL.Kim S.-Y.Fan Y.Bumbu V.Lee DR.Wacharasindhu S.Hong X. Org. Lett. 2005, 7: 143 -
11e
Harmata M.Calkins NL.Baughman RG.Barnes CL. J. Org. Chem. 2006, 71: 3650 -
11f
Harmata M.Chen Y.Barnes CL. Org. Lett. 2007, 9: 4701 -
11g
Harmata M.Ying W.Hong X.Barnes CL. Synthesis 2008, 594 -
11h
Harmata M.Rayanil K.-o.Espejo VR.Barnes CL. J. Org. Chem. 2009, 74: 3214 -
11i
Harmata M.Cai Z.Chen Y. J. Org. Chem. 2009, 74: 5559 -
11j For a review, see:
Harmata M.Hong X. Prog. Heterocycl. Chem. 2008, 19: 1 - 12 For the synthesis of isomeric dihydro
benzothiazines by intramolecular α-arylation of sulfoximines,
see:
Bolm C.Okamura H.Verrucci M. J. Organomet. Chem. 2003, 687: 444 - 13 For the possible precision of such
data, see:
Wernerova M.Hudlicky T. Synlett 2010, 2701 -
14a
García Mancheño O.Dallimore J.Plant A.Bolm C. Org. Lett. 2009, 11: 2429 -
14b
See also reference 2.
- 15
Taylor S.Gullick J.McMorn P.Bethell D.Page PCB.Hancock EF.King F.Hutchings GJ. Top. Catal. 2003, 24: 43 -
16a For
pioneering work on the use of the nosyl group, see:
Fukuyama T.Jow C.-K.Cheung M. Tetrahedron Lett. 1995, 36: 6373 -
16b Here the N-nosyl deprotection was performed following
procedures reported in:
Greene TW.Wuts PGM. Protective Groups in Organic Synthesis 3rd ed.: John Wiley & Sons; New York: 1999. p.603 - 17
Johnson CR.Kirchoff RA.Reischer RJ.Katekar GF. J. Am. Chem. Soc. 1973, 95: 4287 -
18a
N-Cyano sulfoximine 7d was
prepared following reported procedures, see:
García Mancheño O.Bistri O.Bolm C. Org. Lett. 2007, 9: 3809 -
18b See also in:
Pandey A.Bolm C. Synthesis 2010, 2922 -
19a
Bolm C.Hildebrand JP. Tetrahedron Lett. 1998, 39: 5731 -
19b
Bolm C.Hildebrand JP. J. Org. Chem. 2000, 65: 169 -
19c
Bolm C.Hildebrand JP.Rudolph J. Synthesis 2000, 911 -
19d
Bolm C.Martin M.Gibson L. Synlett 2002, 832 - See also:
-
19e
Harmata M.Hong X.Ghosh SK. Tetrahedron Lett. 2004, 45: 5233 -
19f
Harmata M.Hong X. Synlett 2007, 969 -
20a
Bolm C.Sedelmeier J. J. Org. Chem. 2005, 70: 6904 -
20b For a related copper-mediated
N-arylation, see:
Cho G.-Y.Rémy P.Jansson J.Moessner C.Bolm C. Org. Lett. 2004, 6: 3293 - For the synthesis of tert-butylthiosulfinate, see:
-
22a
Weix DJ.Ellman JA. Org. Lett. 2003, 5: 1317 -
22b
Blum SA.Bergman RG.Ellman JA. J. Org. Chem. 2003, 68: 150 -
22c
Cogan DA.Liu G.Kim K.Backes BJ.Ellman JA. J. Am. Chem. Soc. 1998, 120: 8011 -
22d
Liu G.Cogan DA.Ellman JA. J. Am. Chem. Soc. 1997, 119: 9913 -
22e
Weix DJ.Ellman JA. Org. Synth. 2005, 82: 157 -
24a
García Mancheño O.Bolm C. Org. Lett. 2006, 8: 2349 -
24b See also:
García Mancheño O.Bolm C. Chem. Eur. J. 2007, 13: 6674
References
The relative configuration of diastereoisomeric 4-methyl substituted benzothiazines 9b and 9b′ was assigned by comparison with the NMR patterns of reported 4-alkyl substituted analogues (see reference 11a). Accordingly, the relative configuration of their precursors 8b and 8b′ was also established.
23The enantiomeric ratio of 19 was determined by HPLC: Daicel Chiralpack AS, heptane-i-PrOH, 97:3, 0.9 mL˙min-¹, 254 nm, t R1 = 6.3 min, t R2 = 7.7 min.
25The absolute configuration of 7e could be deduced by considering that the nucleophilic substitution of 19 proceeded with inversion of configuration and that the imination occurred under retention. For respective details, see references 22 and 24.